News

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

For Immediate Release

Chicago, IL – August 27, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

For Immediate Release

Chicago, IL – August 27, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Abercrombie & Fitch (ANF) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.5 per share a year ago. These

MasterCraft Boat Holdings, Inc. (MCFT) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to a loss of $0.04 per share a year

For Immediate Release

Chicago, IL – August 27, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

In the second quarter, Abbott Laboratories ABT posted gross profit of $6.29 billion, up 8.9% year over year despite a 5.4% increase in the cost of products sold (excluding amortization expense).

For Immediate Release

Chicago, IL – August 27, 2025 – Zacks Equity Research shares Willdan Group, Inc. WLDN as the Bull of the Day and Eastman Chemical Co. EMN as the Bear of the Day. In addition

IDEXX Laboratories, Inc.’s IDXX second-quarter growth was backed by the robust performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in international CAG

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

BP plc BP has appointed U.S.-based energy technology company Baker Hughes BKR to deliver long-term support services for the Tangguh LNG project in Papua Barat, Indonesia, one of the nation’s most

Equinor ASA EQNR and its partners have announced a fresh oil and gas discovery in the Fram area, located just 9 kilometers north of the prolific Troll field in the North Sea. The find adds to a

Seagate Technology Holdings plc STX is riding a wave of surging demand from cloud, artificial intelligence (AI) and edge computing. The company’s nearline hard drives remain the backbone of

Intuitive Surgical’s ISRG second-quarter 2025 results highlighted an impressive 88% year-over-year surge in single-port (SP) procedures, underscoring the platform’s accelerating momentum within the

CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General

PPL Corporation PPL benefits from digital transformation and automation by using advanced technology to enhance grid reliability, improve operational efficiency, enhance customer experience and meet

For investors seeking momentum, Procure Space ETF UFO is probably on the radar. The fund just hit a 52-week high and is up 89.1% from its 52-week low price of $17.72/share.

But are more gains in

Shell plc SHEL, a British multinational oil and gas company, is on the verge of a major strategic breakthrough in the Eastern Mediterranean, as it is close to getting the development rights for

Eli Lilly and Company LLY announced top-line data from the third of the seven phase III studies evaluating orforglipron, its GLP-1 once-daily oral pill, in patients with type II diabetes and

Smucker (SJM) came out with quarterly earnings of $1.9 per share, missing the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $2.44 per share a year ago. These figures are